Priority Date: 03.03.05 (US 20050658654P)

Anti-angiogenic compounds

  • Application ID: EP10190929
  • Status: The application is deemed to be withdrawn

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company
no operation time available
Technology Company
no operation time available
2 offices
Technology Company
Technology company logo thumb
no operation time available
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Zoetis UK Limited and Pfizer Inc are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 224 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 03.03.2005 - Priority Date (US 20050658654P)
  • 09.03.2011 - Publication A2 (EP2292248)
  • 29.06.2011 - Publication A3 (EP2292248)

IPC Classification